Jack Lin
Stock Analyst at Morgan Stanley
(0.35)
# 4,152
Out of 4,455 analysts
25
Total ratings
23.5%
Success rate
-16.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jack Lin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HCM HUTCHMED (China) | Upgraded: Hold | $14 → $14 | $10.17 | +33.73% | 3 | May 28, 2026 | |
| HKG: 0013 HUTCHMED (China) Limited | Maintained: Hold | $21.45 → $21.30 | $15.83 | +34.55% | 3 | May 28, 2026 | |
| HKG: 9969 InnoCare Pharma Limited | Upgraded: Buy | $19.60 → $17.00 | $10.85 | +56.68% | 3 | May 28, 2026 | |
| HKG: 9606 Duality Biotherapeutics, Inc. | Maintained: Buy | $493.00 | $162.80 | +202.83% | 2 | Nov 20, 2025 | |
| HKG: 9926 Akeso, Inc. | Maintained: Buy | $215.00 | $83.30 | +158.10% | 3 | Nov 9, 2025 | |
| HKG: 9688 Zai Lab Limited | Maintained: Buy | $37.50 → $37.44 | $13.91 | +169.16% | 2 | Nov 6, 2025 | |
| HKG: 9995 RemeGen Co., Ltd. | Maintained: Hold | $89.00 | $69.65 | +27.78% | 2 | Oct 30, 2025 | |
| HKG: 1801 Innovent Biologics, Inc. | Maintained: Buy | $123.00 | $75.15 | +63.67% | 1 | Sep 22, 2025 | |
| HKG: 1952 Everest Medicines Limited | Maintained: Hold | $55.00 | $23.12 | +137.89% | 1 | Sep 22, 2025 | |
| HKG: 2162 Keymed Biosciences Inc. | Maintained: Buy | $93.50 | $64.05 | +45.98% | 1 | Sep 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 → $48 | $18.00 | +166.67% | 3 | Sep 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22.00 | $9.36 | +135.04% | 1 | Sep 19, 2025 |
HUTCHMED (China)
May 28, 2026
Upgraded: Hold
Price Target: $14 → $14
Current: $10.17
Upside: +33.73%
HUTCHMED (China) Limited
May 28, 2026
Maintained: Hold
Price Target: $21.45 → $21.30
Current: $15.83
Upside: +34.55%
InnoCare Pharma Limited
May 28, 2026
Upgraded: Buy
Price Target: $19.60 → $17.00
Current: $10.85
Upside: +56.68%
Duality Biotherapeutics, Inc.
Nov 20, 2025
Maintained: Buy
Price Target: $493.00
Current: $162.80
Upside: +202.83%
Akeso, Inc.
Nov 9, 2025
Maintained: Buy
Price Target: $215.00
Current: $83.30
Upside: +158.10%
Zai Lab Limited
Nov 6, 2025
Maintained: Buy
Price Target: $37.50 → $37.44
Current: $13.91
Upside: +169.16%
RemeGen Co., Ltd.
Oct 30, 2025
Maintained: Hold
Price Target: $89.00
Current: $69.65
Upside: +27.78%
Innovent Biologics, Inc.
Sep 22, 2025
Maintained: Buy
Price Target: $123.00
Current: $75.15
Upside: +63.67%
Everest Medicines Limited
Sep 22, 2025
Maintained: Hold
Price Target: $55.00
Current: $23.12
Upside: +137.89%
Keymed Biosciences Inc.
Sep 22, 2025
Maintained: Buy
Price Target: $93.50
Current: $64.05
Upside: +45.98%
Sep 21, 2025
Maintained: Buy
Price Target: $50 → $48
Current: $18.00
Upside: +166.67%
Sep 19, 2025
Maintained: Buy
Price Target: $22.00
Current: $9.36
Upside: +135.04%